The settlement agreement allows Alvotech and its commercial partners to market and sell the biosimilar as of January 1, 2026 in the United Kingdom and Canada, as well as in Japan (excluding the ...

In this Healio Video Perspective from Retina 2026, Ehsan Rahimy, MD, discusses the potential of IL-6 inhibition for the ...

Manufacturing differences between ranibizumab and aflibercept biosimilars might shape pricing, uptake, and patient access globally.

Eye drop nanoparticles that shrink over time overcome the eye's natural defenses, delivering protein drugs to the retina and ...

As of December 2025, a total of 90 biosimilars across 20 unique biological molecules had been approved in the United States.

Management of geographic atrophy (GA) has changed with the introduction of retinal therapies aimed at slowing disease ...

Abstract: Retinal neovascularization (RNV) is a pathological condition characterized by the abnormal growth of new blood vessels within the retina, commonly found in patients with diabetic retinopathy ...

Closely monitor highly myopic eyes for macular neovascularization-related atrophy, which can develop despite treatment. Approximately 1 in 3 highly myopic eyes without preexisting retinal pigment ...

Image Credit: Getty Images Clinicians and researchers offer insight into the potential for a retinal implant to restore vision lost to geographic atrophy. But recent headlines spanning the general ...

Please provide your email address to receive an email when new articles are posted on . Patients with inherited retinal diseases may present with seemingly routine conditions. Look for comorbid ...

Background: Retinal neovascularization is a significant contributor of vision loss. One of the chemokines found to be elevated in the vitreous samples of diabetic retinopathy patients is IL-8. However ...